Hladun, Grant Warren

Track

Insider profile

Performance

Overall performance
2.2
Performance over holding periods
2.2
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
3 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Hladun, Grant Warren's trades of PharmaCorp Rx Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
441.02
Quantity 45,004 -6.7%
Value CA$3,864,678
Transaction date
Purchase
Price
349.62
Quantity 14,565 -6.4%
Value CA$3,020,245
Transaction date
Purchase
Price
147.38
Quantity 26,345
Value CA$4,923,178
Transaction date
Purchase
Price
0.40
Quantity 250,000
Value CA$100,000
Transaction date
Purchase
Price
0.40
Quantity 500,000
Value CA$200,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-15 2026-07-14
B Purchase
45,004 -6.7%
441.02
CA$3,864,678 		45,004 -6.7% 441.02 CA$3,864,678
2025-11-13 2025-11-12
B Purchase
14,565 -6.4%
349.62
CA$3,020,245 		14,565 -6.4% 349.62 CA$3,020,245
2025-11-13 2025-11-12
B Purchase
26,345
147.38
CA$4,923,178 		26,345 147.38 CA$4,923,178
2024-06-13 2024-06-06
B Purchase
250,000
0.40
CA$100,000 		250,000 0.40 CA$100,000
2024-06-13 2024-06-06
B Purchase
500,000
0.40
CA$200,000 		500,000 0.40 CA$200,000